# Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

> **NCT04221178** · — · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 50 (actual)

## Conditions studied

- Plasma Cell Myeloma

## Interventions

- **OTHER:** Cessation of continuous matinenace therapy

## Key facts

- **NCT ID:** NCT04221178
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-03
- **Primary completion:** 2027-01-03
- **Final completion:** 2027-01-03
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04221178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04221178, "Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04221178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*